Antimicrobial Susceptibilities of Anaerobic Bacteria: Recent Clinical Isolates
AUTOR(ES)
Staneck, Joseph L.
RESUMO
Minimal inhibitory concentrations of clindamycin, minocycline, metronidazole, penicillin, and carbenicillin were determined by agar dilution against 150 recent clinical isolates of anaerobic bacteria. Ninety-nine percent of Bacteroides fragilis and all B. melaninogenicus, Clostridium perfringens, and Fusobacterium were inhibited by clindamycin at 3.1 μg/ml. Only 58% of other clostridial species were inhibited by this concentration of clindamycin. Minocycline at 3.1 μg/ml inhibited 72% of C. perfringens, 81% of other Clostridium species, and 66, 75, and 100% of B. fragilis, B. melaninogenicus, and Fusobacterium, respectively. Metronidazole at 12.5 μg/ml inhibited all bacteria tested. B. fragilis was resistant to both penicillin and carbenicillin at 6.2 μg/ml. Concentrations of 25 μg/ml for penicillin and 100 μg/ml for carbenicillin were needed to inhibit more than 90% of B. fragilis. Organisms other than B. fragilis were moderately or extremely susceptible to the penicillins.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444642Documentos Relacionados
- Antimicrobial Susceptibilities of Clinical Desulfovibrio Isolates
- Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.
- Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
- Comparison of Susceptibilities of Anaerobic Bacteria to Cefmenoxime, Ceftriaxone, and Other Antimicrobial Compounds
- In Vitro Activities of DA-7867, a Novel Oxazolidinone, against Recent Clinical Isolates of Aerobic and Anaerobic Bacteria
